Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 81.36%-1.16B | ---- | -174.40%-6.24B | ---- | -34.33%8.38B | ---- | 4.75%12.77B | ---- | -16.56%12.19B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -34.32%-1B | ---- | 0.00%-746M | ---- | 16.74%-746M | ---- | 11.02%-896M | ---- | -41.43%-1.01B |
| Dividend (income)- adjustment | ---- | 40.67%-601M | ---- | ---1.01B | ---- | ---- | ---- | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | 16.20%-1.11B | ---- | 89.64%-1.32B | ---- | 6.31%-12.75B | ---- | -9.23%-13.6B | ---- | 19.88%-12.46B |
| Impairment and provisions: | ---- | -50.11%942M | ---- | 20.49%1.89B | ---- | -45.38%1.57B | ---- | -20.88%2.87B | ---- | 148.53%3.63B |
| -Impairment of property, plant and equipment (reversal) | ---- | -90.91%18M | ---- | 141.46%198M | ---- | -81.82%82M | ---- | -69.69%451M | ---- | 835.85%1.49B |
| -Impairmen of inventory (reversal) | ---- | -35.21%276M | ---- | 125.40%426M | ---- | -32.50%189M | ---- | 14.29%280M | ---- | 99.19%245M |
| -Other impairments and provisions | ---- | -48.73%648M | ---- | -2.47%1.26B | ---- | -39.38%1.3B | ---- | 12.94%2.14B | ---- | 62.77%1.89B |
| Revaluation surplus: | ---- | 175.00%11M | ---- | -98.99%4M | ---- | --397M | ---- | ---- | ---- | 148.89%22M |
| -Other fair value changes | ---- | 175.00%11M | ---- | -98.99%4M | ---- | --397M | ---- | ---- | ---- | 148.89%22M |
| Asset sale loss (gain): | ---- | -9.55%-711M | ---- | 71.33%-649M | ---- | -667.46%-2.26B | ---- | -459.76%-295M | ---- | 176.64%82M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -111.24%-376M | ---- | 44.20%-178M | ---- | -8.14%-319M | ---- | -459.76%-295M | ---- | 176.64%82M |
| -Loss (gain) from selling other assets | ---- | 28.87%-335M | ---- | 75.78%-471M | ---- | ---1.95B | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | 29.11%6.82B | ---- | 18.96%5.28B | ---- | 12.83%4.44B | ---- | 21.33%3.94B | ---- | 8.82%3.24B |
| -Amortization of intangible assets | ---- | 34.71%1.98B | ---- | 23.28%1.47B | ---- | 2.40%1.19B | ---- | 30.72%1.17B | ---- | 15.99%892M |
| -Other depreciation and amortization | ---- | -38.73%-523M | ---- | ---377M | ---- | ---- | ---- | ---- | ---- | ---- |
| Financial expense | ---- | -24.73%837M | ---- | 8.07%1.11B | ---- | 282.53%1.03B | ---- | -77.69%269M | ---- | 109.74%1.21B |
| Exchange Loss (gain) | ---- | ---- | ---- | ---- | ---- | -166.31%-187M | ---- | 1,126.09%282M | ---- | 253.33%23M |
| Special items | ---- | ---25M | ---- | ---- | ---- | 51.00%-368M | ---- | -464.66%-751M | ---- | 73.66%-133M |
| Adjustment items | ---- | -38.73%-523M | ---- | ---377M | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit before the change of operating capital | ---- | 269.13%3.48B | ---- | -317.24%-2.06B | ---- | -110.77%-493M | ---- | -32.66%4.58B | ---- | 152.60%6.8B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 51.43%-833M | ---- | -67.81%-1.72B | ---- | -197.33%-1.02B | ---- | 269.08%1.05B | ---- | 55.10%-621M |
| Accounts receivable (increase)decrease | ---- | -112.61%-1.26B | ---- | 718.93%9.95B | ---- | -83.42%1.22B | ---- | 350.68%7.33B | ---- | -426.85%-2.92B |
| Accounts payable increase (decrease) | ---- | 265.31%6.3B | ---- | 71.51%-3.81B | ---- | -435.80%-13.38B | ---- | 58.94%3.98B | ---- | -84.50%2.51B |
| prepayments (increase)decrease | ---- | 75.08%-1.02B | ---- | ---4.07B | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items for working capital changes | ---- | -2.37%13.25B | ---- | -39.34%13.57B | ---- | 567.89%22.37B | ---- | -73.19%-4.78B | ---- | 89.71%-2.76B |
| Cash from business operations | -844.09%-9.06B | 67.97%19.92B | 120.71%1.22B | 36.48%11.86B | -175.89%-5.88B | -28.53%8.69B | 79.20%-2.13B | 305.84%12.16B | -304.26%-10.25B | 130.21%3B |
| Other taxs | 77.98%-377M | -10.61%-1.94B | -11.82%-1.71B | -8.75%-1.75B | 13.16%-1.53B | 31.84%-1.61B | -31.27%-1.76B | -132.09%-2.37B | -52.79%-1.34B | 16.54%-1.02B |
| Interest paid - operating | ---- | 31.73%-583M | ---- | -65.50%-854M | ---- | 42.73%-516M | ---- | -4.04%-901M | ---- | -107.18%-866M |
| Net cash from operations | -1,810.93%-9.44B | 88.04%17.4B | 93.34%-494M | 41.01%9.25B | -90.32%-7.41B | -26.21%6.56B | 66.40%-3.9B | 700.45%8.89B | -239.51%-11.59B | 109.61%1.11B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 34.32%1B | ---- | -6.63%746M | ---- | -18.14%799M | ---- | -0.31%976M | ---- | 106.54%979M |
| Dividend received - investment | -37.74%1.89B | -42.78%4.99B | -51.75%3.04B | -41.41%8.71B | -7.41%6.3B | 46.35%14.87B | 1.64%6.8B | -18.46%10.16B | -14.88%6.69B | -10.59%12.46B |
| Restricted cash (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---89M | ---- | ---- |
| Decrease in deposits (increase) | 86.55%-1.06B | -442.62%-22.04B | -547.75%-7.86B | -183.79%-4.06B | --1.76B | -6,321.74%-1.43B | ---- | --23M | ---- | ---- |
| Sale of fixed assets | ---- | -19.37%695M | ---- | -12.13%862M | ---- | 3.15%981M | ---- | 11,787.50%951M | ---- | -97.05%8M |
| Purchase of fixed assets | 11.63%-3.19B | -18.90%-11.66B | ---3.61B | -135.24%-9.81B | ---- | 9.67%-4.17B | ---- | -14.58%-4.61B | ---2.68B | 6.35%-4.03B |
| Purchase of intangible assets | ---- | -104.09%-6.08B | ---- | 28.27%-2.98B | ---- | -96.50%-4.16B | ---- | -41.66%-2.12B | ---- | 0.93%-1.49B |
| Sale of subsidiaries | ---- | ---- | ---- | -91.58%79M | ---- | -55.03%938M | ---- | 39.63%2.09B | ---- | --1.49B |
| Acquisition of subsidiaries | ---- | ---1.12B | ---1.12B | ---- | ---- | -2,306.33%-3.8B | ---- | -116.61%-158M | ---- | --951M |
| Recovery of cash from investments | ---- | -94.76%399M | ---- | 45.09%7.61B | ---- | 14.54%5.25B | ---- | --4.58B | ---- | ---- |
| Cash on investment | ---4.44B | 87.11%-178M | ---- | -7.72%-1.38B | -105.21%-6.5B | 81.30%-1.28B | -521.37%-3.17B | -3,605.41%-6.86B | ---510M | 94.75%-185M |
| Other items in the investment business | -12.40%1.14B | 107.89%158M | -35.81%1.3B | -79.57%76M | -70.48%2.02B | 1.36%372M | 1.92%6.85B | -70.52%367M | 165.65%6.72B | 131.91%1.25B |
| Net cash from investment operations | 31.49%-5.66B | -24,243.88%-33.84B | -331.01%-8.25B | -101.66%-139M | -65.92%3.57B | 57.49%8.37B | 2.51%10.48B | -53.52%5.31B | 530.79%10.23B | 676.77%11.43B |
| Net cash before financing | -72.55%-15.1B | -280.37%-16.44B | -127.81%-8.75B | -38.96%9.11B | -158.28%-3.84B | 5.10%14.93B | 583.06%6.59B | 13.25%14.21B | 76.43%-1.36B | 224.42%12.55B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 632.72%13.17B | -79.62%5.99B | -86.67%1.8B | 62.04%29.4B | -6.01%13.48B | -21.20%18.15B | 145.37%14.34B | -13.10%23.03B | -69.87%5.85B | 12.24%26.5B |
| Refund | -149.68%-11.67B | 47.84%-14.34B | 63.38%-4.67B | -55.29%-27.5B | -65.78%-12.77B | 40.75%-17.71B | 41.05%-7.7B | -96.37%-29.88B | -68.83%-13.06B | -71.81%-15.22B |
| Dividends paid - financing | ---- | 82.38%-460M | 48.72%-20M | -0.04%-2.61B | -680.00%-39M | 41.41%-2.61B | 99.49%-5M | -28.66%-4.45B | -32,433.33%-976M | -3.90%-3.46B |
| Absorb investment income | ---- | --47M | ---- | ---- | ---- | 1,158.64%3.71B | ---- | 175.70%295M | ---- | 81.36%107M |
| Issuance expenses and redemption of securities expenses | ---- | 92.63%-71M | ---- | -935.48%-963M | ---- | ---93M | ---- | ---- | ---- | ---- |
| Other items of the financing business | -3.96%-236M | 569.44%507M | 33.43%-227M | 66.36%-108M | -498.25%-341M | -29.96%-321M | -470.00%-57M | -12.27%-247M | -300.00%-10M | 8.33%-220M |
| Adjustment item of financing business | ---- | ---- | ---- | ---- | ---- | ---- | --1M | ---- | ---- | ---- |
| Net cash from financing operations | 140.36%1.26B | -304.82%-8.9B | -1,032.54%-3.12B | -294.60%-2.2B | -94.91%335M | 110.04%1.13B | 180.23%6.58B | -246.08%-11.26B | -170.33%-8.2B | -31.43%7.71B |
| Effect of rate | 2,265.00%433M | -234.38%-129M | -114.39%-20M | -37.25%96M | 187.42%139M | 148.11%153M | ---159M | ---318M | ---- | ---- |
| Net Cash | -16.53%-13.83B | -466.46%-25.34B | -238.72%-11.87B | -56.95%6.92B | -126.61%-3.51B | 444.99%16.06B | 237.66%13.17B | -85.45%2.95B | -262.84%-9.57B | 1,648.96%20.25B |
| Begining period cash | -35.15%46.98B | 10.71%72.45B | 10.97%72.45B | 33.47%65.44B | 33.17%65.29B | 5.67%49.03B | 5.68%49.03B | 77.49%46.4B | 77.54%46.4B | 4.68%26.14B |
| Cash at the end | -44.55%33.58B | -35.15%46.98B | -2.20%60.56B | 11.05%72.45B | -0.19%61.93B | 33.07%65.24B | 68.46%62.04B | 5.68%49.03B | 15.06%36.83B | 77.54%46.4B |
| Cash balance analysis | ||||||||||
| Cash and bank balance | -51.92%27.41B | -23.82%44.92B | --57.01B | --58.97B | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash and cash equivalent balance | -51.92%27.41B | -23.82%44.92B | --57.01B | --58.97B | ---- | ---- | ---- | ---- | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | Ernst & Young Hua Ming Certified Public Accountants (Special General Partnership), Ernst & Young Accounting Firm | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.